Duty-free access secured under TEPA for range of agricultural & allied products in Norway (See 'Corp Brief') Ministry of Coal launcing aution towards resilient and globally competitive coal ecosystem (See 'Corp Brief') NLDSL Sign MoU to digitize logistics landscape in Maharashtra (See 'Corp Brief') Kavach: Indigenous Technology at Heart of Safety Ecosystem & GPS-Based Fog Devices and Digital Stations (See 'Corp Brief') SHANTI Act, 2025, to scale India's nuclear capacity to ensure long-term energy security and meet Net Zero targets (See 'Corp Brief') Ayush Chintan Shivir 2026 inaugurated (See 'Corp Brief') A&C - Appeal u/s 19 of Contempt of Courts Act, is not maintainable against order that merely calls for documents & details to ascertain whether there has been violation of status quo order: HC (See 'Legal Desk') Union Govt Secy reviews status of Brackish water Aquaculture cluster notified under PMMSY (See 'Corp Brief') Benami - PBPT Act, 1988 cannot be invoked as substitute to hold parties accountable for alleged violations of IRDAI regulations or any fiscal statutes: SAFEMA (See 'Legal Desk') FIU-Pension Fund Authority sign MoU to combat money laundering and financial crimes (See 'Corp Brief') Union Ministry of Health hosts First BRICS Health Working Group Meeting (See 'Corp Brief') AIIA-iCAINE Marks Excellence at MSME Hackathon 5.0 with Breakthrough Idea Selection (See 'Corp Brief') IBC - Once classified as operational debt, municipal dues cannot claim priority outside statutory waterfall mechanism provided u/s 53 of IBC, 2016, during liquidation: HC (See 'Legal Desk') Nationwide 'Nari Shakti Vandan Run' to be held on 17-18 April across 7 Cities (See 'Corp Brief') NBCFDC Registers Record Performance in FY 2025-26 (See 'Corp Brief') DDWS organises 7th District Collectors' Peyjal Samvad (See 'Corp Brief') IPR - Notices contemplated u/s 25(3) of Trademark Act and RG-3 notices to person who is no longer authorized agent does not constitute compliance with statutory mandate: HC (See 'Legal Desk') Corporate laws (Amendment) Bill 2026 - Proposals affecting auditors (See CORP EINSICHT) NIPER Mohali signs grant agreement with Novartis Healthcare (See 'Corp Brief') NFDC announces Nationwide Release of Malayalam Feature Film Achappa's Album (See 'Corp Brief') IPR - Application of trade mark in India to goods to be exported from India constitutes use within India of trade mark for purpose of establishing infringement and passing off: HC (See 'Legal Desk') MoS calls for Strong Clinical Foundation in Medical Education, notwithstanding AI (See 'Corp Brief') IPR - To determine passing off, focus must be on similarities rather than dissimilarities, and meticulous side-by-side dissection is not necessary and trade dress has to be judged as whole: HC (See 'Legal Desk') India Pharma 2026: Spotlight on Policy, Regulation, AI and CRDMO (See 'Corp Brief') MY Bharat Budget Quest 2026 reaches Grand Culmination Across 17 Zones (See 'Corp Brief') IBC - Multi-state co-operative society can invest in another company, including as resolution applicant under IBC, only if target company is either its subsidiary or engaged in same line of business: SC (See 'Legal Desk') India Pharma highlights Policy Push and Innovation Driving Sectoral Growth (See 'Corp Brief') IBC - Once moratorium is imposed, corporate debtor's pre-CIRP dues cannot be set off against deposit held by creditor: SC (See 'Legal Desk') Ministry of Labour signs MoUs with Porter and Gigin Technologies (See 'Corp Brief') FEMA - SCNs alleging contravention of provisions of FERA merit being quashed, where issued after unjustified delay of 7-10 years, more so where record retention norms generally require preservation for 5-8 years: HC (See 'Legal Desk') Medicine is not just profession, it is a commitment to service of humanity: Murmu (See 'Corp Brief') Misc - Once Freezing Authority identifies properties and forms opinion that they are acquired from illicit source of money derived from drug trafficking, burden of proof shifts entirely onto affected persons to controvert allegations: SAFEMA (See 'Legal Desk') Union Minister jighlights Nari Shakti Vandan Adhiniyam as Transformative Reform (See 'Corp Brief') Bizu Festival Celebrations highlight Cultural Pride and Policy Dialogue on Tribal Development (See 'Corp Brief') India, Kuwait emphasize Dialogue Over Conflict to Secure Energy and Trade Supplies (See 'Corp Brief') Misc - There is no right in borrower to personal hearing by banks before classifying their account as fraud account: SC (See 'Legal Desk') Manohar Lal holds Key Engagements on Infrastructure and Development Cooperation (See 'Corp Brief') CARI Bengaluru gets ISO 15189:2022 Accreditation in Biochemistry (See 'Corp Brief') NI Act - At stage of issuance of process, statutory presumption u/s 139 of NI Act cannot be dislodged in summary manner merely by contending that cheque issued was not for legally enforceable debt: SC (See 'Legal Desk') Barabanki to Bahraich Highway to become Key Cross-Border Trade Lifeline (See 'Corp Brief') Advanced Agriculture fest kicks off in Raisen in MP (See 'Corp Brief') PMLA - Sec 2(1)(u) permits attachment of any property of equivalent value, including properties acquired prior to commission of scheduled offence, which are untraceable: SAFEMA (See 'Legal Desk')

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.